Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 8, 2007 - Issue 1
Submit an article Journal homepage
162
Views
14
CrossRef citations to date
0
Altmetric
CASE REPORT

Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment

Murat Eren Ozen Department of Psychiatry, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
,
Mehmet Yumru Department of Psychiatry, Gaziantep University Faculty of Medicine, Gaziantep, TurkeyCorrespondence[email protected]
, MD,
Haluk A. Savas Department of Psychiatry, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
,
Neslihan Cansel Department of Psychiatry, Gaziantep University Faculty of Medicine, Gaziantep, Turkey
&
Hasan Herken Department of Psychiatry, Pamukkale University Faculty of Medicine, Denizli, Turkey
Pages 42-44 | Received 08 Dec 2005, Published online: 12 Jul 2009

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Stephen E Nicolson & Charles B Nemeroff. (2007) Ziprasidone in the treatment of mania in bipolar disorder. Neuropsychiatric Disease and Treatment 3:6, pages 823-834.
Read now
Branimir Margetić & Branka Aukst-Margetić. (2007) Comments on the report of neuroleptic malignant syndrome induced by ziprasidone. The World Journal of Biological Psychiatry 8:2, pages 131-132.
Read now

Articles from other publishers (12)

Yub Raj Sedhai, Alok Atreya, Prabin Phuyal, Soney Basnyat & Sagar Pokhrel. (2021) Case Report: Ziprasidone induced neuroleptic malignant syndrome. F1000Research 10, pages 124.
Crossref
Peter Biro, Dierk A. Vagts, Uta Emmig & Heike KaltofenHeike Kaltofen, Dierk A. Vagts, Uta Emmig & Peter Biro. 2018. Anästhesie bei seltenen Erkrankungen. Anästhesie bei seltenen Erkrankungen 1 3 .
Siddharth Sarkar & Nitin Gupta. (2018) Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: Nuances and pragmatics of the association. BJPsych Bulletin 41:4, pages 211-216.
Crossref
Martino Belvederi Murri, Argentina Guaglianone, Michele Bugliani, Pietro Calcagno, Matteo Respino, Gianluca Serafini, Marco Innamorati, Maurizio Pompili & Mario Amore. (2015) Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis. Drugs in R&D 15:1, pages 45-62.
Crossref
David M Gardner, Andrea L Murphy, Stan Kutcher, Serge Beaulieu, Carlo Carandang, Alain Labelle, Pierre Lalonde, Ashok Malla, Heather Milliken, Claire O’Donovan, Ayal Schaffer, Jorge Soni, Valerie H Taylor & Richard Williams. (2013) Evidence review and clinical guidance for the use of ziprasidone in Canada. Annals of General Psychiatry 12:1, pages 1.
Crossref
Brian D. Berman. (2011) Neuroleptic Malignant Syndrome. The Neurohospitalist 1:1, pages 41-47.
Crossref
Marilyn A. DaviesYvette Conley & Bryan L. Roth. (2010) Functional SNPs in Genes Encoding the 5-HT 2A Receptor Modify the Affinity and Potency of Several Atypical Antipsychotic Drugs . Biological Research For Nursing 13:1, pages 55-60.
Crossref
Peter Biro, Dierk A. Vagts, Uta Emmig & Thomas PaschPeter Biro, Dierk A. Vagts, Uta Emmig & Thomas Pasch. 2011. Anästhesie bei seltenen Erkrankungen. Anästhesie bei seltenen Erkrankungen 155 186 .
Steven C. Stoner & Amy Berry. (2009) Suspected Neuroleptic Malignant Syndrome During Quetiapine-Clozapine Cross-Titration. Journal of Pharmacy Practice 23:1, pages 69-73.
Crossref
Julian N. Trollor, Xiaohua Chen & Perminder S. Sachdev. (2009) Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs. CNS Drugs 23:6, pages 477-492.
Crossref
Victoria Chang & Joseph H Friedman. (2009) Motor side effects of atypical antipsychotic drugs. Therapy 6:2, pages 249-258.
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.